{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:22Z","timestamp":1786119142968,"version":"build-2736575974"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/cad.0b013e3282eea257","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T18:12:49Z","timestamp":1236190369000},"page":"1139-1147","source":"Crossref","is-referenced-by-count":28,"title":["Apoptotic pathway induced by noscapine in human myelogenous leukemic cells"],"prefix":"10.1097","volume":"18","author":[{"given":"Nastaran","family":"Heidari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Goliaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh Rahimi","family":"Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid","family":"Rahbar-Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massoud","family":"Mahmoudian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.cellbio.13.1.83","article-title":"Microtubule polymerization dynamics","volume":"13","author":"Desai","year":"1997","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R2-4-20210227","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/13543776.12.11.1663","article-title":"Discovery and development of anti-mitotic agents that inhibit tubulin polymerisation for the treatment of cancer","volume":"12","author":"Li","year":"2002","journal-title":"Expert Opin Ther Patents"},{"key":"R3-4-20210227","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"R4-4-20210227","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1146\/annurev.med.48.1.353","article-title":"The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents","volume":"48","author":"Rowinsky","year":"1997","journal-title":"Annu Rev Med"},{"key":"R5-4-20210227","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(00)02074-2","article-title":"The taxanes: an update","volume":"355","author":"Crown","year":"2000","journal-title":"Lancet"},{"key":"R6-4-20210227","first-page":"1699","article-title":"Pharmacology, bio-analysis and pharmacokinetics of the vinca alkaloids and semi-synthetic derivatives [review]","volume":"12","author":"Van Tellingen","year":"1992","journal-title":"Anticancer Res"},{"key":"R7-4-20210227","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.seminoncol.2005.11.003","article-title":"Myelotoxicity from chemotherapy","volume":"33","author":"Daniel","year":"2006","journal-title":"Semin Oncol"},{"key":"R8-4-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/01.cco.0000228735.39885.3e","article-title":"Neurological complications of cancer chemotherapy","volume":"18","author":"Hildebrand","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"R9-4-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00128071-200607010-00005","article-title":"Cutaneous reactions to chemotherapy and their management","volume":"7","author":"Wyatt","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"R10-4-20210227","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00232-005-0792-1","article-title":"Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux","volume":"206","author":"Loo","year":"2005","journal-title":"J Membr Biol"},{"key":"R11-4-20210227","first-page":"O1","article-title":"The role of beta-tubulin isotypes in resistance to antimitotic drugs","volume":"1471","author":"Burkhart","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"R12-4-20210227","doi-asserted-by":"crossref","first-page":"17118","DOI":"10.1074\/jbc.272.27.17118","article-title":"Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization","volume":"272","author":"Giannakakou","year":"1997","journal-title":"J Biol Chem"},{"key":"R13-4-20210227","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1440-1797.2005.00429.x","article-title":"Noscapine suppresses angiotensin converting enzyme inhibitors-induced cough","volume":"10","author":"Mooraki","year":"2005","journal-title":"Nephrology (Carlton)"},{"key":"R14-4-20210227","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1556\/APhysiol.88.2001.3-4.5","article-title":"Effect of noscapine, the antitussive opioid alkaloid, on bradykinin-induced smooth muscle contraction in the isolated ileum of the guinea-pig","volume":"88","author":"Mahmoudian","year":"2001","journal-title":"Acta Physiol Hung"},{"key":"R15-4-20210227","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1073\/pnas.95.4.1601","article-title":"Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells","volume":"95","author":"Ye","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-4-20210227","doi-asserted-by":"crossref","first-page":"46697","DOI":"10.1074\/jbc.C100550200","article-title":"Sustained activation of p34cdc2 is required for noscapine-induced apoptosis","volume":"276","author":"Ye","year":"2001","journal-title":"J Biol Chem"},{"key":"R17-4-20210227","doi-asserted-by":"crossref","first-page":"17200","DOI":"10.1074\/jbc.M110369200","article-title":"Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint","volume":"277","author":"Zhou","year":"2002","journal-title":"J Biol Chem"},{"key":"R18-4-20210227","doi-asserted-by":"crossref","first-page":"39777","DOI":"10.1074\/jbc.M203927200","article-title":"Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine","volume":"277","author":"Zhou","year":"2002","journal-title":"J Biol Chem"},{"key":"R19-4-20210227","first-page":"4109","article-title":"Noscapine alters microtubule dynamics in living cells and inhibits the progression of melanoma","volume":"62","author":"Landen","year":"2002","journal-title":"Cancer Res"},{"key":"R20-4-20210227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s002620000109","article-title":"Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses","volume":"49","author":"Ke","year":"2000","journal-title":"Cancer Immunol Immunother"},{"key":"R21-4-20210227","doi-asserted-by":"crossref","first-page":"5187","DOI":"10.1158\/1078-0432.CCR-04-0360","article-title":"Noscapine crosses the blood\u2013brain barrier and inhibits glioblastoma growth","volume":"10","author":"Landen","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R22-4-20210227","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1021\/jm0494220","article-title":"Discovery of S-phase arresting agents derived from noscapine","volume":"48","author":"Anderson","year":"2005","journal-title":"J Med Chem"},{"key":"R23-4-20210227","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1021\/jm050674q","article-title":"Identification of novel and improved antimitotic agents derived from noscapine","volume":"48","author":"Anderson","year":"2005","journal-title":"J Med Chem"},{"key":"R24-4-20210227","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.cellbio.15.1.269","article-title":"Biochemical pathways of caspase activation during apoptosis","volume":"15","author":"Budihardjo","year":"1999","journal-title":"Annu Rev Cell Dev Biol"},{"key":"R25-4-20210227","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1074\/jbc.274.8.5053","article-title":"Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis","volume":"274","author":"Sun","year":"1999","journal-title":"J Biol Chem"},{"key":"R26-4-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1023\/A:1016119328968","article-title":"Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update","volume":"7","author":"Soldani","year":"2002","journal-title":"Apoptosis"},{"key":"R27-4-20210227","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/34112","article-title":"A caspase-activated DNase that degrades DNA during apoptosis and its inhibitor ICAD","volume":"391","author":"Enari","year":"1998","journal-title":"Nature"},{"key":"R28-4-20210227","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm0596-574","article-title":"Involvement of the CD95 (APO-1\/FAS) receptor\/ligand system in drug-induced apoptosis in leukemia cells","volume":"2","author":"Friesen","year":"1996","journal-title":"Nat Med"},{"key":"R29-4-20210227","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V95.1.301","article-title":"Functional CD95 ligand and CD95 death-inducing signaling complex in activation-induced cell death and doxorubicin-induced apoptosis in leukemic T cells","volume":"95","author":"Fulda","year":"2000","journal-title":"Blood"},{"key":"R30-4-20210227","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood.V93.9.3053","article-title":"Anticancer drugs induce caspase-8\/FLICE activation and apoptosis in the absence of CD95 receptor\/ligand interaction","volume":"93","author":"Wesselborg","year":"1999","journal-title":"Blood"},{"key":"R31-4-20210227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.191.1.195","article-title":"Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD\/MORT1 signaling. Implications for cancer therapy","volume":"191","author":"Newton","year":"2000","journal-title":"J Exp Med"},{"key":"R32-4-20210227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/sj.cdd.4401062","article-title":"Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway","volume":"9","author":"Pirnia","year":"2002","journal-title":"Cell Death Differ"},{"key":"R33-4-20210227","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1182\/blood.V98.9.2800","article-title":"Caspase 8 activation independent of Fas (CD95\/APO-1) signaling may mediate killing of B-chronic lymphocytic leukemia cells by cytotoxic drugs or gamma radiation","volume":"98","author":"Jones","year":"2001","journal-title":"Blood"},{"key":"R34-4-20210227","first-page":"471","article-title":"Caspase-9 is the upstream caspase activated by 8-methoxypsoralen and ultraviolet-A radiation treatment of Jurkat T leukemia cells and normal T lymphocytes","volume":"89","author":"Martelli","year":"2004","journal-title":"Haematologica"},{"key":"R35-4-20210227","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.144.2.281","article-title":"Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner","volume":"144","author":"Slee","year":"1999","journal-title":"J Cell Biol"},{"key":"R36-4-20210227","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","article-title":"BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death","volume":"83","author":"McGahon","year":"1994","journal-title":"Blood"},{"key":"R37-4-20210227","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res"},{"key":"R38-4-20210227","first-page":"1853","article-title":"Constitutive expression of human Bcl-2 modulates nitrogen mustard and camptothecin induced apoptosis","volume":"53","author":"Walton","year":"1993","journal-title":"Cancer Res"},{"key":"R39-4-20210227","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"R40-4-20210227","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1126\/science.275.5303.1132","article-title":"The release of cytochrome C from mitochondria: a primary site for Bcl-2 regulation of apoptosis","volume":"275","author":"Kluck","year":"1997","journal-title":"Science"},{"key":"R41-4-20210227","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.cdd.4400739","article-title":"BID-dependent and BID-independent pathways for BAX insertion into mitochondria","volume":"7","author":"Ruffolo","year":"2000","journal-title":"Cell Death Differ"},{"key":"R42-4-20210227","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.bbadis.2005.07.002","article-title":"Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins","volume":"1762","author":"Dejean","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R43-4-20210227","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<527::AID-IJC14>3.0.CO;2-#","article-title":"Late apoptotic effects of taxanes on K562 erythroleukemia cells: apoptosis is delayed upstream of caspase-3 activation","volume":"85","author":"Gangemi","year":"2000","journal-title":"Int J Cancer"},{"key":"R44-4-20210227","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood.V90.11.4283","article-title":"Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis","volume":"90","author":"Martins","year":"1997","journal-title":"Blood"},{"key":"R45-4-20210227","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.cdd.4400406","article-title":"The CD95\/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis","volume":"5","author":"Tolomeo","year":"1998","journal-title":"Cell Death Differ"},{"key":"R46-4-20210227","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1182\/blood.V97.5.1378","article-title":"Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95\/Fas receptor\u2013ligand interaction and occurs downstream of caspase-3","volume":"97","author":"Wieder","year":"2001","journal-title":"Blood"},{"key":"R47-4-20210227","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0006-2952(00)00481-0","article-title":"Caspase-8 activation independent of CD95\/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4)","volume":"60","author":"Goncalves","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"R48-4-20210227","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1006\/mcbr.1999.0146","article-title":"A crucial role of caspase 3 and caspase 8 in paclitaxel-induced apoptosis","volume":"2","author":"Oyaizu","year":"1999","journal-title":"Mol Cell Biol Res Commun"},{"key":"R49-4-20210227","doi-asserted-by":"crossref","first-page":"22625","DOI":"10.1074\/jbc.270.38.22625","article-title":"Regulation of the Fas apoptotic cell death pathway by Abl","volume":"270","author":"McGahon","year":"1995","journal-title":"J Biol Chem"},{"key":"R50-4-20210227","first-page":"147","article-title":"Induction of death (CD95\/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma","volume":"2","author":"Munker","year":"1996","journal-title":"Cytokines Mol Ther"},{"key":"R51-4-20210227","first-page":"3062","article-title":"Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells","volume":"61","author":"Jiang","year":"2001","journal-title":"Cancer Res"},{"key":"R52-4-20210227","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/MCB.19.12.8469","article-title":"BCL-2 is phosphorylated and inactivated by ASK\/Jun N-terminal protein kinase pathway normally activated at G2\/M","volume":"19","author":"Yamamoto","year":"1999","journal-title":"Mol Cell Biol"},{"key":"R53-4-20210227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.onc.1208189","article-title":"Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation\/dephosphorylation cycle associated with apoptosis induction","volume":"24","author":"Du","year":"2005","journal-title":"Oncogene"},{"key":"R54-4-20210227","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0889-8588(18)30104-7","article-title":"Bcl-2: prevention of apoptosis as a mechanism of drug resistance","volume":"9","author":"Reed","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"R55-4-20210227","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"R56-4-20210227","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/nar\/26.1.205","article-title":"IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools","volume":"26","author":"Hainaut","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"R57-4-20210227","first-page":"82","article-title":"Recent progress in clinical application of noscapine: a review","volume":"10","author":"Mahmoudian","year":"2006","journal-title":"Curr Topics Pharmacol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e3282eea257","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:39:15Z","timestamp":1786037955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200711000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3282eea257","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}